Coronary restenosis elimination with a sirolimus eluting stent; First European human experience with 6-month angiographic and intravascular ultrasonic follow-up
Open Access
- 15 November 2001
- journal article
- research article
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 22 (22) , 2125-2130
- https://doi.org/10.1053/euhj.2001.2892
Abstract
Aims Coronary stenting is limited by a 10%–60% restenosis rate due to neointimal hyperplasia. Sirolimus is a macrocyclic lactone agent that interactsKeywords
This publication has 0 references indexed in Scilit: